TerminatedPhase 2NCT00058448
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Studying Malignant tumor of penis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Tomasz M. Beer, MDOHSU Knight Cancer Institute
- Intervention
- docetaxel(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2004 – 2005
Study locations (30)
- St. Anthony Central Hospital, Denver, Colorado, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado, United States
- Veterans Affairs Medical Center - Denver, Denver, Colorado, United States
- Montrose Memorial Hospital Cancer Center, Montrose, Colorado, United States
- St. Anthony North Hospital, Westminster, Colorado, United States
- Exempla Lutheran Medical Center, Wheat Ridge, Colorado, United States
- Salina Regional Health Center, Salina, Kansas, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- CCOP - Montana Cancer Consortium, Billings, Montana, United States
- Deaconess Billings Clinic - Downtown, Billings, Montana, United States
- Northern Rockies Radiation Oncology Center, Billings, Montana, United States
- St. Vincent Healthcare, Billings, Montana, United States
- Deaconess Billings Clinic Cancer Center, Billings, Montana, United States
- Bozeman Deaconess Hospital, Bozeman, Montana, United States
- St. James Community Hospital, Butte, Montana, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Eastern Cooperative Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00058448 on ClinicalTrials.govOther trials for Malignant tumor of penis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07110038DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile CarcinomaInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- RECRUITINGPHASE2NCT06353906Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile CancerThe Netherlands Cancer Institute
- ACTIVE NOT RECRUITINGPHASE3NCT06465914A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese MalesShanghai Bovax Biotechnology Co., Ltd.
- ENROLLING BY INVITATIONNCT06565585Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell CarcinomaUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPHASE2NCT06415318TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile CancerSun Yat-sen University
- RECRUITINGPHASE1NCT05999396FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal CancerGerman Cancer Research Center
- RECRUITINGPHASE2NCT06104618Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the PenisMayo Clinic
- RECRUITINGNANCT05899361A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestDana-Farber Cancer Institute